- $2 million in funding was secured by submitting a research grant proposal to the Department of Defense. The funding was used for early commercial development of new wound-care products. For more information, click here.
- Implemented a recruitment strategy for surgeons and clinical sites to ensure completion of clinical studies for the company's leading bone repair product. For more information, click here.
- 20% sales increase was generated by conducting a strategic market research analysis and developing new business opportunities. For more information, click here.
- Spearheaded strategic market research and developed a potential new product containing an injectable percutaneous cartilage-repair compound. For more information, click here.
- Provided technical support for Internet sales and marketing research that enhanced the company's website presence; information was linked to database system. For more information, click here.
- Expanded the product database, created new product datasheets and labels, and enhanced marketing promotions.
- Optimized the company's website presence by providing technical support for Internet sales and marketing research.
- Targeted and identified 60 companies that company contacted with out-licensing opportunities. Three companies expressed an interest in licensing contracts. For more information, click here.
- Spearheaded business development and market/product research that revealed key out-licensing/in-licensing opportunities; due diligence of nanotechnology startup led to acquisition of the company. Initiation of NPV, P&L analyses of new regenerative medicine, hard and soft tissue, and wound-care products provided strategic direction for senior management.
- Utilized FDA QSR standards, ISO regulations, and design controls for new medical devices and adult cell-based combination biologic products. Development of pre-launch product brochures and business prospectus for cell/scaffold-based spine fusion, bone repair, and soft tissue products promoted new product and marketing development.
- Managed research of new treatment modalities for spinal fusion; the data and findings were published in spine journal. Model was used at a biosciences lab, and FDA approval was eventually secured. For more information, click here.
- Secured basic research and training financing with NIH grants to investigate reproductive, regenerative medicine, and wound repair. Several clinical trials for potential new therapeutic treatments resulted.
- Managed and secured budgeting of GLP-level clinical and pre-clinical research development programs for spine fusion, cartilage regeneration, and cardiovascular repair. FDA & foreign regulatory submissions resulted.
- Drove patent-filing initiative and created procedures that resulted in the filing of four new global patents. For more information, click here.
- Filed U.S. and foreign patent applications for translational research performed at academic research laboratories.
- Led pre-clinical animal model for spinal fusion using stem cells and biomaterial scaffold that demonstrated stem cells and biomaterial scaffold could result in good spinal fusion efficacy. For more information, click here.
- Published more than 30 peer-reviewed publications in the field of endocrinology, orthopedic regenerative medicine, and wound repair.
- Designed and launched an MS SharePoint-based competitive technology and business intelligence knowledge portal system that included RSS feeds, discussion board, and external web links. For more information, click here.
- Collaborated with Director of Marketing and Product Development to penetrate the orthopedic bone repair market; a clinical trial study was submitted to the FDA. For more information, click here.
- Founded a startup company to develop patented technologies and secured financing from several government agencies. For more information, click here.
|
to view details. 
to go back to the Competencies Chart.
WORD Download
PDF Print
Linked In
Zoom Info